(ATMU) Atmus Filtration - Overview
Sector: Consumer CyclicalIndustry: Auto Parts | Exchange NYSE (USA) | Currency USD | Market Cap: 4.732m | Total Return 56.2% in 12m
Stock: Filters, Chemicals, Technology, Services
Total Rating 83
Risk 92
Buy Signal -0.11
| Risk 5d forecast | |
|---|---|
| Volatility | 33.3% |
| Relative Tail Risk | -8.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.40 |
| Alpha | 41.17 |
| Character TTM | |
|---|---|
| Beta | 1.032 |
| Beta Downside | 0.542 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.76% |
| CAGR/Max DD | 1.51 |
EPS (Earnings per Share)
Revenue
Description: ATMU Atmus Filtration March 04, 2026
Atmus Filtration Technologies Inc. (ATMU) designs and manufactures filtration products for a global market under its Fleetguard brand. The companys product portfolio includes fuel, lube, air, and hydraulic filters, as well as coolants and other chemicals.
ATMU serves both on-highway commercial vehicles and off-highway sectors such as agriculture, construction, mining, and power generation. This business model relies on recurring sales of consumable filtration products essential for equipment maintenance and longevity.
Beyond physical products, ATMU develops filtration technologies and offers service solutions. These include remote digital diagnostic and prognostic platforms, reflecting a trend towards predictive maintenance in industrial sectors.
For further data-driven insights, explore ValueRays comprehensive analysis of ATMU.
Headlines to watch out for
- Commercial vehicle production rates impact filter demand
- Raw material price fluctuations affect production costs
- Regulatory emissions standards drive new filter technology adoption
- Aftermarket parts sales provide recurring revenue stream
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 207.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 6.24 > 1.0 |
| NWC/Revenue: 29.71% < 20% (prev 24.56%; Δ 5.15% < -1%) |
| CFO/TA 0.15 > 3% & CFO 202.7m > Net Income 207.4m |
| Net Debt (333.6m) to EBITDA (330.5m): 1.01 < 3 |
| Current Ratio: 2.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (82.4m) vs 12m ago -1.32% < -2% |
| Gross Margin: 28.88% > 18% (prev 0.28%; Δ 2.86k% > 0.5%) |
| Asset Turnover: 138.9% > 50% (prev 140.3%; Δ -1.40% > 0%) |
| Interest Coverage Ratio: 9.00 > 6 (EBITDA TTM 330.5m / Interest Expense TTM 33.4m) |
Altman Z'' 5.65
| A: 0.39 (Total Current Assets 892.4m - Total Current Liabilities 368.2m) / Total Assets 1.35b |
| B: 0.34 (Retained Earnings 454.6m / Total Assets 1.35b) |
| C: 0.24 (EBIT TTM 300.5m / Avg Total Assets 1.27b) |
| D: 0.40 (Book Value of Equity 386.5m / Total Liabilities 972.2m) |
| Altman-Z'' Score: 5.65 = AAA |
Beneish M -2.90
| DSRI: 1.19 (Receivables 320.1m/254.2m, Revenue 1.76b/1.67b) |
| GMI: 0.97 (GM 28.88% / 27.92%) |
| AQI: 0.92 (AQ_t 0.19 / AQ_t-1 0.21) |
| SGI: 1.06 (Revenue 1.76b / 1.67b) |
| TATA: 0.00 (NI 207.4m - CFO 202.7m) / TA 1.35b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of ATMU shares?
As of March 27, 2026, the stock is trading at USD 59.19 with a total of 754,322 shares traded.
Over the past week, the price has changed by +4.76%, over one month by -7.73%, over three months by +10.90% and over the past year by +56.15%.
Over the past week, the price has changed by +4.76%, over one month by -7.73%, over three months by +10.90% and over the past year by +56.15%.
Is ATMU a buy, sell or hold?
Atmus Filtration has received a consensus analysts rating of 4.29.
Therefore, it is recommended to buy ATMU.
- StrongBuy: 3
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ATMU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 71.6 | 21% |
| Analysts Target Price | 71.6 | 21% |
ATMU Fundamental Data Overview March 25, 2026
P/E Trailing = 23.224
P/S = 2.6823
P/B = 12.0013
Revenue TTM = 1.76b USD
EBIT TTM = 300.5m USD
EBITDA TTM = 330.5m USD
Long Term Debt = 540.0m USD (from longTermDebt, last quarter)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 570.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 333.6m USD (from netDebt column, last quarter)
Enterprise Value = 5.07b USD (4.73b + Debt 570.0m - CCE 236.4m)
Interest Coverage Ratio = 9.00 (Ebit TTM 300.5m / Interest Expense TTM 33.4m)
EV/FCF = 34.05x (Enterprise Value 5.07b / FCF TTM 148.8m)
FCF Yield = 2.94% (FCF TTM 148.8m / Enterprise Value 5.07b)
FCF Margin = 8.43% (FCF TTM 148.8m / Revenue TTM 1.76b)
Net Margin = 11.76% (Net Income TTM 207.4m / Revenue TTM 1.76b)
Gross Margin = 28.88% ((Revenue TTM 1.76b - Cost of Revenue TTM 1.25b) / Revenue TTM)
Gross Margin QoQ = 28.53% (prev 29.46%)
Tobins Q-Ratio = 3.75 (Enterprise Value 5.07b / Total Assets 1.35b)
Interest Expense / Debt = 1.40% (Interest Expense 8.00m / Debt 570.0m)
Taxrate = 21.31% (13.0m / 61.0m)
NOPAT = 236.5m (EBIT 300.5m * (1 - 21.31%))
Current Ratio = 2.42 (Total Current Assets 892.4m / Total Current Liabilities 368.2m)
Debt / Equity = 1.51 (Debt 570.0m / totalStockholderEquity, last quarter 378.5m)
Debt / EBITDA = 1.01 (Net Debt 333.6m / EBITDA 330.5m)
Debt / FCF = 2.24 (Net Debt 333.6m / FCF TTM 148.8m)
Total Stockholder Equity = 324.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.32% (Net Income 207.4m / Total Assets 1.35b)
RoE = 63.97% (Net Income TTM 207.4m / Total Stockholder Equity 324.2m)
RoCE = 34.77% (EBIT 300.5m / Capital Employed (Equity 324.2m + L.T.Debt 540.0m))
RoIC = 26.14% (NOPAT 236.5m / Invested Capital 904.5m)
WACC = 8.70% (E(4.73b)/V(5.30b) * Re(9.61%) + D(570.0m)/V(5.30b) * Rd(1.40%) * (1-Tc(0.21)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.66%
[DCF] Terminal Value 77.42% ; FCFF base≈112.0m ; Y1≈123.5m ; Y5≈159.4m
[DCF] Fair Price = 26.02 (EV 2.45b - Net Debt 333.6m = Equity 2.12b / Shares 81.5m; r=8.70% [WACC]; 5y FCF grow 11.81% → 3.0% )
EPS Correlation: 59.46 | EPS CAGR: 1.13% | SUE: 1.72 | # QB: 3
Revenue Correlation: 79.97 | Revenue CAGR: 4.22% | SUE: 2.09 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.78 | Chg7d=+0.012 | Chg30d=+0.012 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-12-31): EPS=2.95 | Chg7d=+0.047 | Chg30d=+0.094 | Revisions Net=+2 | Growth EPS=+7.9% | Growth Revenue=+13.0%
EPS next Year (2027-12-31): EPS=3.21 | Chg7d=+0.030 | Chg30d=+0.030 | Revisions Net=+1 | Growth EPS=+8.9% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.3% (Discount Rate 9.6% - Earnings Yield 4.3%)
[Growth] Growth Spread = +6.8% (Analyst 12.1% - Implied 5.3%)
P/S = 2.6823
P/B = 12.0013
Revenue TTM = 1.76b USD
EBIT TTM = 300.5m USD
EBITDA TTM = 330.5m USD
Long Term Debt = 540.0m USD (from longTermDebt, last quarter)
Short Term Debt = 30.0m USD (from shortTermDebt, last quarter)
Debt = 570.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 333.6m USD (from netDebt column, last quarter)
Enterprise Value = 5.07b USD (4.73b + Debt 570.0m - CCE 236.4m)
Interest Coverage Ratio = 9.00 (Ebit TTM 300.5m / Interest Expense TTM 33.4m)
EV/FCF = 34.05x (Enterprise Value 5.07b / FCF TTM 148.8m)
FCF Yield = 2.94% (FCF TTM 148.8m / Enterprise Value 5.07b)
FCF Margin = 8.43% (FCF TTM 148.8m / Revenue TTM 1.76b)
Net Margin = 11.76% (Net Income TTM 207.4m / Revenue TTM 1.76b)
Gross Margin = 28.88% ((Revenue TTM 1.76b - Cost of Revenue TTM 1.25b) / Revenue TTM)
Gross Margin QoQ = 28.53% (prev 29.46%)
Tobins Q-Ratio = 3.75 (Enterprise Value 5.07b / Total Assets 1.35b)
Interest Expense / Debt = 1.40% (Interest Expense 8.00m / Debt 570.0m)
Taxrate = 21.31% (13.0m / 61.0m)
NOPAT = 236.5m (EBIT 300.5m * (1 - 21.31%))
Current Ratio = 2.42 (Total Current Assets 892.4m / Total Current Liabilities 368.2m)
Debt / Equity = 1.51 (Debt 570.0m / totalStockholderEquity, last quarter 378.5m)
Debt / EBITDA = 1.01 (Net Debt 333.6m / EBITDA 330.5m)
Debt / FCF = 2.24 (Net Debt 333.6m / FCF TTM 148.8m)
Total Stockholder Equity = 324.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.32% (Net Income 207.4m / Total Assets 1.35b)
RoE = 63.97% (Net Income TTM 207.4m / Total Stockholder Equity 324.2m)
RoCE = 34.77% (EBIT 300.5m / Capital Employed (Equity 324.2m + L.T.Debt 540.0m))
RoIC = 26.14% (NOPAT 236.5m / Invested Capital 904.5m)
WACC = 8.70% (E(4.73b)/V(5.30b) * Re(9.61%) + D(570.0m)/V(5.30b) * Rd(1.40%) * (1-Tc(0.21)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.66%
[DCF] Terminal Value 77.42% ; FCFF base≈112.0m ; Y1≈123.5m ; Y5≈159.4m
[DCF] Fair Price = 26.02 (EV 2.45b - Net Debt 333.6m = Equity 2.12b / Shares 81.5m; r=8.70% [WACC]; 5y FCF grow 11.81% → 3.0% )
EPS Correlation: 59.46 | EPS CAGR: 1.13% | SUE: 1.72 | # QB: 3
Revenue Correlation: 79.97 | Revenue CAGR: 4.22% | SUE: 2.09 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.78 | Chg7d=+0.012 | Chg30d=+0.012 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-12-31): EPS=2.95 | Chg7d=+0.047 | Chg30d=+0.094 | Revisions Net=+2 | Growth EPS=+7.9% | Growth Revenue=+13.0%
EPS next Year (2027-12-31): EPS=3.21 | Chg7d=+0.030 | Chg30d=+0.030 | Revisions Net=+1 | Growth EPS=+8.9% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.3% (Discount Rate 9.6% - Earnings Yield 4.3%)
[Growth] Growth Spread = +6.8% (Analyst 12.1% - Implied 5.3%)